Nanotechnology NewsNanotech transforms cyclosporine into safer transplant drugFierceDrugDeliveryThe Times of India reports that researchers at the University of Strathclyde in Scotland are working on a nano-sized drug particle version of cyclosporine, …
WANEFDA Approves Inlyta To Treat Patients With a Type of Advanced Kidney CancerSacramento BeeRecently approved drugs for the treatment of kidney cancer include sorafenib (2005), sunitinib (2006), temsirolimus (2007), everolimus (2009), bevacizumab (200…
Steroid-Sparing Renal Transplant Yields Successful OutcomesDoctors LoungeAcute rejection rates were 31 and 25 percent, respectively, and chronic rejection due to interstitial fibrosis/tubular atrophy occurred in 47 and 39 percent of LD and DD recipient…
The Express TribuneQ&A: What does Ontario's first cardiac stem cell transplant mean for Canadians?Global TorontoToronto doctors have performed Ontario's first cardiac stem cell transplant using bone marrow cells of the patient in question. …
Sycamore Shoals Hospital receives certification for congestive heart failure …Elizabethton StarBy Ashley Rader Sycamore Shoals Hospital recently received the Joint Commission's Advanced Certification for congestive heart failure for its high-qual…
Regenerative medicine company encouraged by heart failure trialMedCity NewsRegenerative medicine company Juventas Therapeutics is touting the results from 12-month data of a phase 1 clinical trial of heart failure patients. At 12 months, heart failure …
ABC NewsKidney Donor Gives Organ to Stranger on a WhimABC NewsBut last June, the 55-year-old professor gave doctoral student John Young — a virtual stranger — her kidney, enduring every invasive test and eventually transplant surgery to save his life…
Oakdale Legislators Address PFCs, Government Efficiency, Organ Donation in New …Patch.comChuck Wiger, would create a license plate that says “Become an organ donor and save a life.” To get the plates, drivers would have to pay a $10 fee, plus mak…
Asian Scientist MagazineTakeda's Orteronel (TAK-700) Enters Phase III Clinical Trials For Prostate CancerAsian Scientist MagazineThe first (C21004) is a randomized, double-blind and multi-center trial of prednisolone plus orteronel or placebo in pa…
ImmunoGen, Inc. Reports Second Quarter Fiscal Year 2012 Financial Results and …MarketWatch (press release)Phase II trials are now in process that evaluate SAR3419: (1) as a single agent for diffuse large B-cell lymphoma (DLBCL); (2) in combination wi…